BWCS
GILD icon

Beirne Wealth Consulting Services’s Gilead Sciences GILD Stock Holding History

Beirne Wealth Consulting Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,475
Closed -$226K – 153
2019
Q1 		$226K Buy
+3,475
New +$231K 0.18% 160

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Beirne Wealth Consulting Services's GILD Position: Q2 2019 in Review

Beirne Wealth Consulting Services sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 3,475 shares — an estimated $226K sold.

Beirne Wealth Consulting Services first reported a position in GILD in Q1 2019 and held it in 1 quarter. The position peaked at $226K in Q1 2019. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Beirne Wealth Consulting Services reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • Beirne Wealth Consulting Services sold 3,475 Gilead Sciences shares in Q2 2019, an estimated $226K.
  • Beirne Wealth Consulting Services first reported a position in Gilead Sciences in Q1 2019 and held it in 1 quarter.
  • Beirne Wealth Consulting Services's Gilead Sciences position peaked at $226K in Q1 2019.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Beirne Wealth Consulting Services's 13F filing for Q2 2019, filed 25 Jul 2019.